Search results
Showing 826 to 840 of 1688 results for carers
Tebentafusp for treating advanced (unresectable or metastatic) uveal melanoma [ID1441]
In development [GID-TA10428] Expected publication date: TBC
NICE's impact on the prescribing of antipsychotic medicines in people living with dementia
Guselkumab for treating moderately to severely active ulcerative colitis ID6237
In development [GID-TA11247] Expected publication date: TBC
Pirtobrutinib for untreated chronic lymphocytic leukaemia or small lymphocytic lymphoma [ID6397]
In development [GID-TA11501] Expected publication date: TBC
PillCam COLON 2 for investigation of the colon through direct visualisation
In development [GID-DG10083] Expected publication date: 17 July 2025
This guideline covers diagnosis and management of thyroid cancer in people aged 16 and over. It aims to reduce variation in practice and increase the quality of care and survival for people with thyroid cancer.
Strimvelis for treating adenosine deaminase deficiency–severe combined immunodeficiency (HST7)
Evidence-based recommendation on Strimvelis for adenosine deaminase deficiency–severe combined immunodeficiency.
In development [GID-TA11298] Expected publication date: TBC
Depemokimab for treating severe eosinophilic asthma in people 12 years and over ID6447
Awaiting development [GID-TA11553] Expected publication date: TBC
Digital platforms to support self-management of asthma : early value assessment
Awaiting development [GID-HTE10063] Expected publication date: TBC
An outline of the roles and responsibilities of the National Institute for Health and Care Excellence
Drug-eluting coronary stents for treating coronary artery disease: late-stage assessment
In development [GID-HTE10039] Expected publication date: 12 May 2025
This guideline covers assessing all chronic pain (chronic primary pain, chronic secondary pain, or both) and managing chronic primary pain in people aged 16 years and over. Chronic primary pain is pain with no clear underlying cause, or pain (or its impact) that is out of proportion to any observable injury or disease.
Evidence-based recommendations on tenecteplase (Metalyse) for treating acute ischaemic stroke in adults.
Alcohol-mediated perivascular renal sympathetic denervation for resistant hypertension
In development [GID-IPG10299] Expected publication date: 05 February 2025